Flourish Research logo “For 30 years, Diablo has built its reputation ... N.C., will acquire the Australian pharmaceutical company Mayne Pharma Group, which has its U.S. headquarters in Raleigh.

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on OrthoPediatrics (KIDS – Research Report) and ...

The Boards of Directors of both companies have approved the transaction and Mayne Pharma’s Board of Directors has unanimously recommended that its shareholders vote in favor of the transaction.

Private equity-backed US pharmaceutical giant Cosette has made a $672 million cash takeover bid for women’s health and dermatology group Mayne Pharmaceuticals. The company, which last week ...

Cosette Pharmaceuticals Inc, which is backed by Avista Healthcare Partners and Hamilton Lane, has agreed to acquire Mayne Pharma, an Australian specialty pharmaceutical company, for $430 million.

The Boards of Directors of both companies have approved the transaction and Mayne Pharma’s Board of Directors has unanimously recom Mayne Pharma Group Limited (Mayne Pharma or the Company ...

Pubs baron Bruce Mathieson, a major investor in Mayne Pharma, is backing a $672m takeover offer for the drugs maker by US giant Cosette. Mayne told shareholders that in the absence of a better ...

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe ...